Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that revolutionizes the utilization of oncolytic viruses through an allogeneic cell-based delivery system. Calidi Biotherapeutics is developing this effective combination of stem cells and oncolytic virus (SN-V1c-vaccinia virus) for use in a variety of difficult-to-treat oncology indications.